AAAAAA
Results: 1-25/43
Authors:
MOOR E
SILVEIRA A
VANTHOOFT F
TORNVALL P
BLOMBACK M
WIMAN B
RYDEN L
HAMSTEN A
Citation: E. Moor et al., COAGULATION-FACTOR-V (ARG(506)-]GLN) MUTATION AND EARLY SAPHENOUS-VEIN GRAFT OCCLUSION AFTER CORONARY-ARTERY BYPASS-GRAFTING, Thrombosis and haemostasis, 80(2), 1998, pp. 220-224
Authors:
SUI GC
WIMAN B
Citation: Gc. Sui et B. Wiman, FUNCTIONAL-EFFECTS OF SINGLE AMINO-ACID SUBSTITUTIONS IN THE REGION OF PHE(113) TO ASP(138) IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 MOLECULE, Biochemical journal, 331, 1998, pp. 409-415
Authors:
BAVENHOLM P
DEFAIRE U
LANDOU C
EFENDIC S
NILSSON J
WIMAN B
HAMSTEN A
Citation: P. Bavenholm et al., PROGRESSION OF CORONARY-ARTERY DISEASE IN YOUNG MALE POSTINFARCTION PATIENTS IS LINKED TO DISTURBANCES OF CARBOHYDRATE AND LIPOPROTEIN METABOLISM AND TO IMPAIRED FIBRINOLYTIC FUNCTION, European heart journal, 19(3), 1998, pp. 402-410
Authors:
NORDENHEM A
WIMAN B
Citation: A. Nordenhem et B. Wiman, TISSUE-PLASMINOGEN ACTIVATOR (TPA) ANTIGEN IN PLASMA - CORRELATION WITH DIFFERENT TPA INHIBITOR COMPLEXES/, Scandinavian journal of clinical & laboratory investigation, 58(6), 1998, pp. 475-483
Authors:
SUI GC
WIMAN B
Citation: Gc. Sui et B. Wiman, STABILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 - ROLE OF TYROSINE(221), FEBS letters, 423(3), 1998, pp. 319-323
SOLUBLE FIBRIN IN PLASMA AS A SIGN OF ACTIVATED COAGULATION IN PATIENTS WITH PREGNANCY COMPLICATIONS
Authors:
OSTLUND E
BREMME K
WIMAN B
Citation: E. Ostlund et al., SOLUBLE FIBRIN IN PLASMA AS A SIGN OF ACTIVATED COAGULATION IN PATIENTS WITH PREGNANCY COMPLICATIONS, Acta obstetricia et gynecologica Scandinavica, 77(2), 1998, pp. 165-169
Authors:
FALK G
SARTORI MT
PATRASSI GM
VETTORE S
GIROLAMI A
WIMAN B
Citation: G. Falk et al., IDENTIFICATION OF AN 18 BASEPAIR DELETION IN THE PAI-1 GENE PROMOTER REGION IN A FAMILY WITH THROMBOTIC DISEASE, FIBRINOLYSIS & PROTEOLYSIS, 11(5-6), 1997, pp. 239-244
Authors:
HELD C
HJEMDAHL P
REHNQVIST N
WALLEN NH
FORSLUND L
BJORKANDER I
ANGELIN B
WIMAN B
Citation: C. Held et al., HEMOSTATIC MARKERS, INFLAMMATORY PARAMETERS AND LIPIDS IN MALE AND FEMALE-PATIENTS IN THE ANGINA PROGNOSIS STUDY IN STOCKHOLM (APSIS) - A COMPARISON WITH HEALTHY CONTROLS, Journal of internal medicine, 241(1), 1997, pp. 59-69
Authors:
HELD C
HJEMDAHL P
REHNQVIST N
WALLEN NH
FORSLUNG L
BJORKANDER I
ERIKSSON SV
WIMAN B
Citation: C. Held et al., CARDIOVASCULAR PROGNOSIS IN RELATION TO FIBRINOGEN, BETA-THROMBOGLOBULIN, OROSOMUCOID AND WHITE BLOOD-CELLS IN PATIENTS WITH STABLE ANGINA-PECTORIS, Thrombosis and haemostasis, 1997, pp. 2238-2238
Authors:
WINNERKVIST A
WIMAN B
VALEN G
VAAGE J
Citation: A. Winnerkvist et al., OXIDATIVE STRESS AND RELEASE OF TISSUE-PLASMINOGEN ACTIVATOR IN ISOLATED RAT HEARTS, Thrombosis research, 85(3), 1997, pp. 245-257
Authors:
NORDENHEM A
WIMAN B
Citation: A. Nordenhem et B. Wiman, PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) CONTENT IN PLATELETS FROM HEALTHY-INDIVIDUALS GENOTYPED FOR THE 4G 5G POLYMORPHISM IN THE PAI-1 GENE/, Scandinavian journal of clinical & laboratory investigation, 57(5), 1997, pp. 453-461
Authors:
BERGMAN AC
LINDER C
SAKAGUCHI K
STENLINDER M
ALAIYA AA
FRANZEN B
SHOSHAN MC
BERGMAN T
WIMAN B
AUER G
APPELLA E
JORNVALL H
LINDER S
Citation: Ac. Bergman et al., INCREASED EXPRESSION OF ALPHA-ENOLASE IN C-JUN TRANSFORMED RAT FIBROBLASTS WITHOUT INCREASED ACTIVATION OF PLASMINOGEN, FEBS letters, 417(1), 1997, pp. 17-20
Authors:
BOKAREWA MI
FALK G
BREMME K
BLOMBACK M
WIMAN B
Citation: Mi. Bokarewa et al., SEARCH FOR MUTATIONS IN THE GENES FOR COAGULATION-FACTOR-V AND COAGULATION-FACTOR-VIII WITH A POSSIBLE PREDISPOSITION TO ACTIVATED PROTEIN-C RESISTANCE, European journal of clinical investigation, 27(4), 1997, pp. 340-345
Authors:
HELD C
HJEMDAHL P
REHNQVIST N
WALLEN H
BJORKANDER I
ERIKSSON SV
FORSLUND L
WIMAN B
Citation: C. Held et al., FIBRINOLYTIC VARIABLES AND CARDIOVASCULAR PROGNOSIS IN PATIENTS WITH STABLE ANGINA-PECTORIS TREATED WITH VERAPAMIL OR METOPROLOL - RESULTS FROM THE ANGINA PROGNOSIS STUDY IN STOCKHOLM, Circulation, 95(10), 1997, pp. 2380-2386
Authors:
BROIJERSEN A
ERIKSSON M
WIMAN B
ANGELIN B
HJEMDAHL P
Citation: A. Broijersen et al., GEMFIBROZIL TREATMENT OF COMBINED HYPERLIPOPROTEINEMIA - NO IMPROVEMENT OF FIBRINOLYSIS DESPITE MARKED REDUCTION OF PLASMA TRIGLYCERIDE LEVELS, Arteriosclerosis, thrombosis, and vascular biology, 16(4), 1996, pp. 511-516
Authors:
GILLIS C
BENGTSSON L
WIMAN B
HAEGERSTRAND A
Citation: C. Gillis et al., SECRETION OF PROSTACYCLIN, TISSUE-PLASMINOGEN ACTIVATOR AND ITS INHIBITOR BY CULTURED ADULT HUMAN ENDOTHELIAL-CELLS GROWN ON DIFFERENT MATRICES, European journal of vascular and endovascular surgery, 11(2), 1996, pp. 127-133
Authors:
SCHULMAN S
WIMAN B
CARLSSON A
GUSTAFSSON C
GRONDAHL A
RHEDIN AS
TORNEBOHM E
JOHANSSON M
LOCKNER D
LINDMARKER P
JOHNSSON H
NICOL P
KOBOSKO J
MALMROS B
ARCINI N
SAAW J
LOOGNA E
STIG R
VIERING S
LJUNGBERG B
WILHELMSSON S
OHLSSON A
WALTER H
MALMQVIST K
ALKHALILI F
LEIJD B
PETRESCU A
BROHULT J
LARFARS G
HULTING J
EKLUND SG
SVENSSON E
DAHLIN L
BOBERG J
NORDLANDER S
MARJANOVICS B
LINDER O
JONSSON KA
MALM C
HJORTH M
FAGRELL B
KALLNER M
GRANQVIST S
EGBERG N
SCHULMAN S
WADMAN B
SNYDER M
Citation: S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
Authors:
WINNERKVIST A
WIMAN B
VALEN G
VAAGE J
Citation: A. Winnerkvist et al., RELEASE OF TISSUE-PLASMINOGEN ACTIVATOR DURING REPERFUSION AFTER DIFFERENT TIMES OF ISCHEMIA IN ISOLATED, PERFUSED RAT HEARTS, Thrombosis research, 82(6), 1996, pp. 533-542
Authors:
HELD C
HJEMDAHL P
REHNQVIST N
WALLEN HN
FORSLUND L
BJORKANDER I
ERIKSSON SV
WIMAN B
Citation: C. Held et al., FIBRINOLYTIC PARAMETERS ARE ASSOCIATED WITH THE RISK FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ANGINA-PECTORIS ON ANTIANGINAL TREATMENT, Circulation, 94(8), 1996, pp. 457-457
Authors:
WIMAN B
Citation: B. Wiman, PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN PLASMA - ITS ROLE IN THROMBOTIC DISEASE, Thrombosis and haemostasis, 74(1), 1995, pp. 71-76
Authors:
WIMAN B
Citation: B. Wiman, PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN PLASMA - ITS ROLE IN THROMBOTIC DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1138-1138
Authors:
HELD C
BJORKANDER I
FORSLUND L
WALLEN H
WIMAN B
RENNQVIST N
HJEMDAHL P
Citation: C. Held et al., FIBRINOLYSIS AND PLATELET ACTIVATION IN PATIENTS WITH STABLE ANGINA-PECTORIS AND MATCHED CONTROLS - A COMPARISON OF RESTING LEVELS AND REACTIVITY DURING EXERCISE, Thrombosis and haemostasis, 73(6), 1995, pp. 1148-1148
Authors:
BROIJERSEN A
ERIKSSON M
WIMAN B
ANGELIN B
HIEMDAHL P
Citation: A. Broijersen et al., EFFECTS OF GEMFIBROZIL ON FIBRINOLYSIS AND THROMBIN GENERATION IN MENWITH COMBINED HYPERLIPIDEMIA, Thrombosis and haemostasis, 73(6), 1995, pp. 1391-1391
Authors:
SJOSTROM I
FALK G
EDSTROM H
KRONVALL G
ULLBERG M
WIMAN B
Citation: I. Sjostrom et al., COMPARISON OF 2 PLASMINOGEN-BINDING PROTEINS PURIFIED FROM DIFFERENT STRAINS OF HAEMOPHILUS-INFLUENZAE, Thrombosis and haemostasis, 73(6), 1995, pp. 1415-1415
Authors:
FALK G
ALMQVIST A
NORDENHEM A
SVENSSON H
WIMAN B
Citation: G. Falk et al., ALLELE-SPECIFIC PCR FOR DETECTION OF A SEQUENCE POLYMORPHISM IN THE PROMOTER REGION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE, Fibrinolysis, 9(3), 1995, pp. 170-174